RNA Therapeutics Market
RNA Therapeutics Market - Global Industry Assessment & Forecast
#
Pages:
198
Base Year:
2023
Feb - 2024
Format:
Report Code:
VMR-2429
Segments Covered
By
Product Vaccines, Drugs
-
By
Туре mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Other Therapeutics
-
By
Indication Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Other Indications
-
By
End User Hospitals and Clinics, Research Settings
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 13.3 Billion |
 Revenue 2032:
|
USD 21.43 Billion |
 Revenue CAGR
(2024 - 2032): |
5.45% |
Fastest Growing Region (2024 -
2032)
|
Europe |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
RNA Therapeutics Market Segment Analysis
- RNA Therapeutics Product Outlook (Revenue, USD Million, 2018 - 2030)
- Vaccines
- Drugs
- RNA Therapeutics Туре Outlook (Revenue, USD Million, 2018 - 2030)
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- RNA Therapeutics Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- RNA Therapeutics End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals and Clinics
- Research Settings
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America RNA Therapeutics Market, by Product
- Vaccines
- Drugs
-
North America RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
-
North America RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
-
North America RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- U.S.
- U.S. RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- U.S. RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- U.S. RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- U.S. RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- U.S. RNA Therapeutics Market, by Product
- Canada
- Canada RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Canada RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Canada RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Canada RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Canada RNA Therapeutics Market, by Product
-
Mexico
- Mexico RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Mexico RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Mexico RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Mexico RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Mexico RNA Therapeutics Market, by Product
-
North America RNA Therapeutics Market, by Product
- Europe
-
Europe RNA Therapeutics Market, by Product
- Vaccines
- Drugs
-
Europe RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
-
Europe RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
-
Europe RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- U. K.
- U.K. RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- U.K. RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- U.K. RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- U.K. RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- U.K. RNA Therapeutics Market, by Product
- France
- France RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- France RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- France RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- France RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- France RNA Therapeutics Market, by Product
-
Germany
- Germany RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Germany RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Germany RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Germany RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Germany RNA Therapeutics Market, by Product
-
Italy
- Italy RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Italy RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Italy RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Italy RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Italy RNA Therapeutics Market, by Product
-
Spain
- Spain RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Spain RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Spain RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Spain RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Spain RNA Therapeutics Market, by Product
-
Rest of Europe
- Rest of Europe RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Rest of Europe RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Rest of Europe RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Rest of Europe RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Rest of Europe RNA Therapeutics Market, by Product
-
Europe RNA Therapeutics Market, by Product
- Asia Pacific
-
Asia Pacific RNA Therapeutics Market, by Product
- Vaccines
- Drugs
-
Asia Pacific RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
-
Asia Pacific RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
-
Asia Pacific RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- China
- China RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- China RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- China RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- China RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- China RNA Therapeutics Market, by Product
- Japan
- Japan RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Japan RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Japan RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Japan RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Japan RNA Therapeutics Market, by Product
-
Germany
- Germany RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Germany RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Germany RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Germany RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Germany RNA Therapeutics Market, by Product
-
India
- India RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- India RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- India RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- India RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- India RNA Therapeutics Market, by Product
-
South Korea
- South Korea RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- South Korea RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- South Korea RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- South Korea RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- South Korea RNA Therapeutics Market, by Product
-
South East Asia
- South East Asia RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- South East Asia RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- South East Asia RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- South East Asia RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- South East Asia RNA Therapeutics Market, by Product
-
Rest of Asia Pacific
- Rest of Asia Pacific RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Rest of Asia Pacific RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Rest of Asia Pacific RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Rest of Asia Pacific RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Rest of Asia Pacific RNA Therapeutics Market, by Product
-
Asia Pacific RNA Therapeutics Market, by Product
- Latin America
-
Latin America RNA Therapeutics Market, by Product
- Vaccines
- Drugs
-
Latin America RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
-
Latin America RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
-
Latin America RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Brazil
- Brazil RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Brazil RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Brazil RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Brazil RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Brazil RNA Therapeutics Market, by Product
- Argentina
- Argentina RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Argentina RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Argentina RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Argentina RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Argentina RNA Therapeutics Market, by Product
-
Rest of Latin America
- Rest of Latin America RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Rest of Latin America RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Rest of Latin America RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Rest of Latin America RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Rest of Latin America RNA Therapeutics Market, by Product
-
Latin America RNA Therapeutics Market, by Product
- Middle East & Africa
-
Middle East & Africa RNA Therapeutics Market, by Product
- Vaccines
- Drugs
-
Middle East & Africa RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
-
Middle East & Africa RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
-
Middle East & Africa RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- GCC Countries
- GCC Countries RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- GCC Countries RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- GCC Countries RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- GCC Countries RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- GCC Countries RNA Therapeutics Market, by Product
- South Africa
- South Africa RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- South Africa RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- South Africa RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- South Africa RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- South Africa RNA Therapeutics Market, by Product
-
Rest of Middle East & Africa
- Rest of Middle East & Africa RNA Therapeutics Market, by Product
- Vaccines
- Drugs
- Rest of Middle East & Africa RNA Therapeutics Market, by Туре
- mRNA Therapeutics
- RNA Interference (RNAi) Therapeutics
- Antisense Oligonucleotide (ASO) Therapeutics
- Other Therapeutics
- Rest of Middle East & Africa RNA Therapeutics Market, by Indication
- Infectious Diseases
- Rare Genetic Diseases/Hereditary Diseases
- Other Indications
- Rest of Middle East & Africa RNA Therapeutics Market, by End User
- Hospitals and Clinics
- Research Settings
- Rest of Middle East & Africa RNA Therapeutics Market, by Product
-
Middle East & Africa RNA Therapeutics Market, by Product
- North America
FAQ
Frequently Asked Question
What is the global demand for RNA Therapeutics in terms of revenue?
-
The global RNA Therapeutics valued at USD 13.3 Billion in 2023 and is expected to reach USD 21.43 Billion in 2032 growing at a CAGR of 5.45%.
Which are the prominent players in the market?
-
The prominent players in the market are Moderna, Inc., BioNTech SE, CureVac N.V., Arcturus Therapeutics, Translate Bio, Inc., GSK plc., Argos Therapeutics Inc., Sangamo Therapeutics, Inc., Pfizer Inc., AstraZeneca plc., CRISPR Therapeutics AG.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 5.45% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the RNA Therapeutics include
- Advances in molecular biology have deepened our understanding of RNA's pivotal role in genetic regulation and disease pathways, propelling the exploration of RNA therapeutics for diverse disorders
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the RNA Therapeutics in 2023.
